Immunosuppressive Factors in Human Cancer

This publication has 100 references indexed in Scilit:

• Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor
  Cancer Immunology, Immunotherapy, 1991
• Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide
  Cancer Immunology, Immunotherapy, 1990
• Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF
  International Journal of Cancer, 1990
• Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor β1, and recombinant tumor necrosis factor α, in normal and neoplastic cells
  Experimental Cell Research, 1989
• Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: Immunosuppression, immunogenicity, and relation to immunosuppressive tumor products
  Cancer Immunology, Immunotherapy, 1989
• Inhibition of in vitro immunocyte function by sera from cattle with bovine leukosis
  Veterinary Immunology and Immunopathology, 1988
• Purification to homogeneity and biochemical characterization of two suppressor factors from human malignant T-cells
  Biochemical and Biophysical Research Communications, 1988
• Heterogeneity of Soluble Suppressor Factors in Rat Malignant Ascites
  Oncology, 1988
• Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope Proteins
  Science, 1985
• Murine leukemia. Proposed role for gangliosides in immune suppression
  European Journal of Cancer and Clinical Oncology, 1982